SARS-CoV-2 Neutralizing Antibodies 3rd Edition
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Coronaviruses".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 1298
Special Issue Editor
Special Issue Information
Dear Colleagues,
At the end of 2019, SARS-CoV-2 was discovered and quickly spread around the world, posing a severe threat to global public health systems. The pandemic resulted in more than 765 million confirmed cases and nearly 7 million associated deaths. Although WHO declared COVID-19 to no longer be a global health emergency on 5 May 2023, the undeniable truth is that the disease is “here to stay” due to its continued evolution. We have witnessed the successful development of a series of vaccines, monoclonal antibodies, highly concentrated immunoglobulin, and convalescent plasma for preventative and therapeutic use during the past 4 years. The neutralizing antibodies in those products play an important role. Although a correlation between neutralizing antibodies and protection has not yet been determined, it is generally believed that the higher the titer of neutralizing antibodies, the better the efficacy. Thus, it is important to identify the correlation between neutralizing antibodies and efficacy. Moreover, different neutralization assays used in different laboratories are variable, and results from different laboratories on neutralizing antibodies may not be comparable. Thus, research concerning standardized neutralizing assays and standards around neutralizing antibodies against SARS-CoV-2 and its variants is still needed.
In this Special Issue, we continue to focus on neutralization assays, assay validation, detection procedures, neutralizing antibody standards and references, as well as the antibody immune response induced by vaccines and the hybrid immunity. We seek contributions featuring original research and review articles, as well as short communications, on this topic.
Prof. Dr. Youchun Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- neutralizing antibodies
- neutralization assays
- standards
- monoclonal antibodies
- vaccines
- viral variants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
